AngioInsight, Inc is a pioneering company based in Ann Arbor, MI, dedicated to revolutionizing the care of coronary artery disease through the use of artificial intelligence and computational modeling. Their mission is to empower cardiologists with advanced anatomical and physiological diagnostics, enhancing clinical decisions, improving patient outcomes, and reducing treatment costs.
With a focus on coronary artery disease, the most prevalent form of heart disease in the United States, AngioInsight leverages cutting-edge technology within the cardiac cath lab. By harnessing the power of artificial intelligence and computational modeling, they provide cardiologists with a quantitative assessment of stenosis severity and a non-invasive determination of Fractional Flow Reserve (FFR), enabling personalized treatment decisions for patients.
Generated from the website